Biotech
Córdoba Biotech Seeks Entrepreneurs to Promote a Hub Focused on Biotech Projects
Córdoba Biotech Incubator specializes in biotechnology, offering three types of incubation: physical with labs, coworking, and virtual. It supports startups through tailored programs based on project maturity—validation, MVP development, and growth. Located in Córdoba’s Science and Technology Park, it provides non-reimbursable grants, expert mentoring, and a conducive environment for biotech innovation and entrepreneurship.
Promoted by the Municipal Institute for Economic Development and Employment of the City Council of Córdoba (IMDEEC), the University of Córdoba (UCO) and the Foundation for Biomedical Research of Córdoba (FIBICO), the new High Technology Incubator Córdoba Biotech opens the period to select 33 ideas, projects or companies that are developed in its different incubation modalities completely free of charge.
The differential advantage of the Córdoba Biotech Incubator is that it focuses on the bio sectors, having laboratories in its facilities for its own use and shared by its incubators
Córdoba Biotech offers three types of incubation: physical with its own laboratories and offices, physical with laboratories and a coworking area, and virtual incubation, focused on companies, initiatives and projects that are both local and from any geographical area.
For selected biotech companies, the Córdoba Biotech High Technology Incubator has a specific area for landing projects that facilitates the participation of initiatives in a preliminary phase, allowing them to validate their idea before joining one of the three phases into which the incubation program is divided, according to their degree of maturity. “Ready”, conceived for projects pending validation of their hypothesis and development of their business model; “Steady”, for those that have a first MVP; and “Go” focused on the acceleration and growth of projects, consolidating the structure of the company.
Specific Córdoba Biotech programs, specialized mentoring, seminars, webinars, masterclasses, forums, conferences and Business Angel networks are part of the support and advisory actions aimed at improving the business idea and the competitiveness of the incubated entrepreneurs.
Non-reimbursable grants for incubated biotechnology companies
In parallel, IMDEEC has opened a line of non-reimbursable aid for biotechnology companies, which companies linked to the Córdoba Biotech Incubator may apply for.
Free accommodation, direct advice from UCO and FIBICO on incubated projects, and the location of Córdoba Biotech in the Orión building, owned by IMDEEC, located in the Córdoba Science and Technology Park, next to the Rabanales University Campus, give CÓRDOBA BIOTECH a privileged position as a High Technology Incubator specialising in the Biotechnology sector.
The call for incubation is open to any of the incubation modalities offered, having constituted a broad profile of beneficiaries: business projects; Bio Startups; researchers; Spin-off and Spin-out; Technology-Based Companies (EBT); Knowledge-Based Companies (EBC); having an innovative technology-based business initiative/project, and framed in the bio-technological sector.
The Córdoba Biotech Incubator, supported by the INCYDE Foundation, is co-financed by the European Regional Development Fund within the Spanish Pluriregional Operational Programme FEDER 2014-2020 PO.
__
(Featured image by National Cancer Institute via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in el confidencial. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Markets1 week ago
Coffee Markets Retreat Amid Speculation, Weather Challenges Persist
-
Crypto9 hours ago
El Salvador To Change BTC Policy to Access IMF Loan of $1 Billion
-
Crowdfunding2 weeks ago
i-RFK Next Raises $3.1 Million on Mamacrowd to Acquire Nuzo and Create Digital Marketing Hub
-
Cannabis6 days ago
Brazil and the Medical Cannabis Revolution, an Overview of Growth and Challenges